How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

In patients with ulcerative colitis who had endoscopic healing, achieving transmural healing was associated with longer relapse-free survival. Women and those who had received multiple advanced ...

Artificial intelligence (AI) systems show high potential for detecting mucosal healing in ulcerative colitis with optimal diagnostic performance, according to a new systematic review and meta-analysis ...

Medically reviewed by Mary Choy, PharmD Key Takeaways Biologic medications help reduce inflammation in ulcerative colitis. If you're new to biologics, infliximab might be your first option for ...

DelveInsight's Ulcerative Colitis Market Insights report includes a comprehensive understanding of current treatment practices, ulcerative colitis emerging drugs, market share of individual therapies, ...

Although not currently recommended as a formal therapeutic target in ulcerative colitis (UC) management, histologic healing is associated with improved long-term clinical outcomes. In a small ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the large intestine, causing persistent inflammation in the colon and rectum. The condition typically begins in the rectum ...

Pain in inflammatory bowel disease is not only about tissue damage. Fear and distress are hidden drivers that intensify ...

Despite endoscopic remission, patients with Crohn’s disease (CD) or ulcerative colitis (UC) may have persistent histologic activity. Researchers performed a systematic review and meta-analysis to ...

What Is Proctitis and How Does It Compare to UC? Proctitis is inflammation of the rectum, the last part of the large intestine that connects the colon to the anus. Ulcerative colitis (UC) is a type of ...